Viewing Study NCT00248157


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-30 @ 3:50 AM
Study NCT ID: NCT00248157
Status: TERMINATED
Last Update Posted: 2012-05-01
First Post: 2005-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module